Compugen (CGEN) furnishes Q3 2025 results press release on 6-K

Compugen Ltd. (CGEN) filed a Form 6-K stating it furnished a press release with the company’s third quarter 2025 results as Exhibit 99.1.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Compugen Ltd. (CGEN) filed a Form 6-K stating it furnished a press release with the company’s third quarter 2025 results as Exhibit 99.1. The filing notes that, with the exception of quotes attributed to Eran Ophir, Ph.D., the press release is incorporated by reference into the company’s effective Form F-3 registration statement (File No. 333-270985).

The report was signed by Eran Ben Dor, General Counsel, on November 10, 2025. Investors seeking financial details should refer to Exhibit 99.1, which contains the full Q3 2025 results.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Compugen (CGEN) file?

A Form 6-K furnishing a press release containing the company’s Q3 2025 results as Exhibit 99.1.

Is the press release part of Compugen’s shelf registration?

Yes. Except for quotes by Eran Ophir, Ph.D., it is incorporated by reference into Form F-3 File No. 333-270985.

Where can I find the Q3 2025 financial details for CGEN?

In Exhibit 99.1 to the Form 6-K, which contains the full Q3 2025 results press release.

Who signed the Form 6-K for Compugen?

Eran Ben Dor, General Counsel.

When was the Form 6-K dated?

November 10, 2025.

What content is excluded from incorporation by reference?

Quotes attributed to Eran Ophir, Ph.D., are excluded from incorporation into the Form F-3.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/10/2025 - 07:00 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 000-30902

COMPUGEN LTD.

(Translation of registrant’s name into English)

26 Harokmim Street

Holon 5885849, Israel

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Compugen Ltd.

On November 10, 2025, Compugen Ltd. (the “Company”) issued a press release reporting the Company’s third quarter 2025 results (the “Press Release”), a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K.

With the exception of the quotes attributable to Eran Ophir, Ph.D., information contained in the Press Release is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, File No. 333-270985.

Exhibit

Number

Description of Exhibit

99.1	Press Release dated November 10, 2025 – “Compugen Reports Third Quarter 2025 Results”

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COMPUGEN LTD.

Date: November 10, 2025	By:	/s/ Eran Ben Dor
		Eran Ben Dor General Counsel

Source: View Original Filing on SEC EDGAR